Eli Lilly and Company, a pharmaceutical company based in Indianapolis, Indiana, revealed it has teamed up with Amazon Pharmacy to help deliver its Zepbound weight loss drug and other medicines straight to customers' homes.
It struck a partnership deal with the online pharmacy subsidiary of Amazon Inc. just four months after obtaining the required regulatory approval to sell its diabetes treatment under a different name and category: weight loss.
Lilly's Weight Loss Treatment
According to CBS News, Eli Lilly's Tirzepatide drug, currently sold as a Mounjaro brand for diabetes, is now on the market under the new name Zepbound. It is also advertised as a weight-loss medication administered using an injection pen.
The company reportedly started selling Zepbound earlier this year. The drugs are directly sold to patients. Patients consult with doctors and obtain prescriptions from digital pharmacies, and the drugs are delivered to them.
Amazon Pharmacy Added as Home Delivery Option
Its partnership with Amazon's pharmacy unit allows patients and customers to obtain their medications quickly. In addition to Amazon Pharmacy, Eli Lilly delivers drugs to its customers via Truepill.
"Lilly has selected Amazon Pharmacy as a dispensing pharmacy option, allowing patients to receive fast, free delivery of medications and 24/7 access to clinical pharmacists," Dr. Vin Gupta, Amazon Pharmacy's chief medical officer, said in a press release. "To help patients being treated for diabetes, obesity, and migraine, Amazon Pharmacy is now offering home delivery of select medications through LillyDirect."
Dr. Gupta added, "Lilly has selected Amazon Pharmacy to serve as a third-party dispensing provider for LillyDirect Pharmacy Solutions, delivering prescribed Lilly medications directly to a patient's home."
Photo by: James Yarema/Unsplash


US Judge Dismisses Gautam Adani Criminal Charges
ASX Faces Legal Action Over Failed Blockchain CHESS Project
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Airbus Joins Air India A320 Altitude Drop Probe
Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Hanwha Offers Up to $1.2 Billion for Austal US Business
ADNOC Gas Targets Up to $4B Profit in 2026
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Shein Scales Back Vietnam Operations as US Trade Rules Shift
OpenAI Restricts Astra AI Over Cyberattack Risks
CBA Posts Record A$10.98B Profit Despite Cautious Outlook 



